Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
|
|
Akero Therapeutics, Inc. (AKRO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/04/2023 |
4
| Cheng Andrew (President and CEO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 8,868 shares
@ $46.057, valued at
$408.4k
Sold 5,300 shares
@ $46.8836, valued at
$248.5k
Sold 2,662 shares
@ $48.5632, valued at
$129.3k
Sold 1,700 shares
@ $49.7059, valued at
$84.5k
Sold 6,470 shares
@ $50.5619, valued at
$327.1k
Exercised 25,000 options to buy
@ $6.36, valued at
$159k
|
|
| 10/04/2023 |
4
| Young Jonathan (COO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 490 shares
@ $51.1, valued at
$25k
Exercised 490 options to buy
@ $21.1, valued at
$10.3k
|
|
| 08/10/2023 |
4
| Graham G. Walmsley (Director) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Bought 25,000 shares
@ $42.059, valued at
$1.1M
|
|
| 08/03/2023 |
4
| Cheng Andrew (President and CEO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 13,679 shares
@ $42.8514, valued at
$586.2k
Sold 11,321 shares
@ $43.5211, valued at
$492.7k
Exercised 25,000 options to buy
@ $6.36, valued at
$159k
|
|
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2023 |
4
| Cheng Andrew (President and CEO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 18,730 shares
@ $44.6606, valued at
$836.5k
Sold 5,051 shares
@ $45.3615, valued at
$229.1k
Sold 1,219 shares
@ $46.2896, valued at
$56.4k
Exercised 25,000 options to buy
@ $6.36, valued at
$159k
|
|
| 06/15/2023 |
4
| White William Richard (CFO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 606 shares
@ $55.16, valued at
$33.4k
|
|
| 06/15/2023 |
4
| Cheng Andrew (President & CEO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 1,613 shares
@ $55.16, valued at
$89k
|
|
| 06/15/2023 |
4
| Rolph Timothy (Chief Scientific Officer) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 509 shares
@ $55.16, valued at
$28.1k
|
|
| 06/15/2023 |
4
| Young Jonathan (COO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 538 shares
@ $55.16, valued at
$29.7k
|
|
| 06/15/2023 |
4
| Yale Catriona (Chief Development Officer) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 591 shares
@ $55.16, valued at
$32.6k
|
|
| 06/05/2023 |
4
| Cheng Andrew (President and CEO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 3,914 shares
@ $44.1752, valued at
$172.9k
Sold 20,686 shares
@ $45.2562, valued at
$936.2k
Sold 400 shares
@ $45.897, valued at
$18.4k
Exercised 21,330 options to buy
@ $0.615, valued at
$13.1k
Exercised 3,670 options to buy
@ $6.36, valued at
$23.3k
|
|
| 05/23/2023 |
4
| Graham G. Walmsley (Director) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Bought 400,000 shares
@ $26, valued at
$10.4M
Bought 120,000 shares
@ $42, valued at
$5M
|
|
| 05/03/2023 |
4
| Cheng Andrew (President & CEO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 21,523 shares
@ $45.0049, valued at
$968.6k
Sold 3,477 shares
@ $45.5045, valued at
$158.2k
Exercised 40,000 options to buy
@ $0.615, valued at
$24.6k
Exercised 25,000 options to buy
@ $0.615, valued at
$15.4k
|
|
| 04/05/2023 |
4
| Cheng Andrew (President & CEO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 23,292 shares
@ $37.8783, valued at
$882.3k
Sold 1,708 shares
@ $38.8259, valued at
$66.3k
Exercised 25,000 options to buy
@ $0.615, valued at
$15.4k
|
|
| 03/14/2023 |
4
| White William Richard (CFO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 641 shares
@ $43.47, valued at
$27.9k
|
|
| 03/14/2023 |
4
| Yale Catriona (Chief Development Officer) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 701 shares
@ $43.46, valued at
$30.5k
|
|
| 03/14/2023 |
4
| Young Jonathan (COO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 634 shares
@ $43.47, valued at
$27.6k
|
|
| 03/14/2023 |
4
| Rolph Timothy (Chief Scientific Officer) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 603 shares
@ $43.47, valued at
$26.2k
|
|
| 03/14/2023 |
4
| Cheng Andrew (President & CEO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,706 shares
@ $43.47, valued at
$74.2k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Yale Catriona (Chief Development Officer) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 1,048 shares
@ $49.1187, valued at
$51.5k
Sold 1,534 shares
@ $49.8901, valued at
$76.5k
Sold 1,313 shares
@ $51.1784, valued at
$67.2k
Sold 1,105 shares
@ $51.987, valued at
$57.4k
|
|
| 01/11/2023 |
4
| Lamy Patrick (See Remarks) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $44.37, valued at
$4.4M
|
|
| 01/05/2023 |
4
| Cheng Andrew (President & CEO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 13,200 shares
@ $50.1199, valued at
$661.6k
Sold 3,800 shares
@ $50.8194, valued at
$193.1k
Sold 3,000 shares
@ $52.0319, valued at
$156.1k
Sold 800 shares
@ $53.0878, valued at
$42.5k
Sold 3,900 shares
@ $54.371, valued at
$212k
Sold 300 shares
@ $54.8067, valued at
$16.4k
Exercised 25,000 options to buy
@ $0.615, valued at
$15.4k
|
|
| 01/05/2023 |
4
| Young Jonathan (COO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 8,777 shares
@ $54.6383, valued at
$479.6k
Exercised 8,777 options to buy
@ $0.615, valued at
$5.4k
|
|
| 12/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/28/2022 |
4
| Young Jonathan (COO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 12,500 shares
@ $49.5687, valued at
$619.6k
Exercised 11,778 options to buy
@ $6.36, valued at
$74.9k
Exercised 722 options to buy
@ $0.615, valued at
$444 |
|
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2022 |
4
| Young Jonathan (COO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Granted 29,073 options to buy
@ $21.1, valued at
$613.4k
|
|
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|